Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma

BackgroundChildren with craniopharyngiomas (CPs) typically suffer from a life-long chronic disease. The younger the child, the more vulnerable the maturing brain is to invasive therapies such as surgery or radiotherapy. Therefore, treatment modalities facilitating avoidance or delay of invasive ther...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Cora Hedrich, Priya Patel, Lukas Haider, Tracey Taylor, Elaine Lau, Roxanne Hook, Christian Dorfer, Karl Roessler, Natalia Stepien, Maria Aliotti Lippolis, Hannah Schned, Clara Koeller, Lisa Mayr, Amedeo A. Azizi, Andreas Peyrl, Bienvenido Ros Lopez, Alvaro Lassaletta, Julie Bennett, Johannes Gojo, Ute Bartels
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2024-07-01
Schriftenreihe:	Frontiers in Oncology
Schlagworte:	craniopharyngioma intracystic treatment peginterferon alfa-2a pediatric neurooncology pediatric neurosurgery
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1401761/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!